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Background. Clinical or echocardiographic mid-term responses to cardiac resynchronization therapy (CRT) may have a difference influence 
on long-term prognosis of heart failure (HF) patients. The aim of the study was to establish which definition of CRT response, clinical or 
echocardiographic, best predicts long-term prognosis.
Methods. A total of 663 HF patients underwent a complete history and physical examination and transthoracic echocardiogram prior to CRT 
implantation and at 6 months follow-up. The clinical and echocardiographic responses to CRT were defined based on clinical improvement (≥1 
NYHA class) and LV reverse remodeling (reduction of LV end-systolic volume≥15%), respectively. All patients were prospectively followed-up for the 
occurrence of death.
Results. At 6 months follow-up, 510 (77%) patients showed clinical response to CRT and 412 (62%) patients showed echocardiographic response 
to CRT. During a mean follow-up of 37±22 months, 140 (21%) patients died. Clinical and echocardiographic CRT responses were both significantly 
related to all-cause mortality (Figure). However, on multivariable Cox regression analysis only echocardiographic response to CRT was independently 
associated with a superior survival (hazard ratio:0.38; 95% CI,0.27-0.50; p<0.001).
Conclusions. In a large population of CRT patients, the reduction of LV end-systolic volume at mid-term follow-up demonstrated to be a better 
predictor of long-term survival than improvement in clinical status
